How Much Does Retatrutide Cost Online in 2026?

Research-grade retatrutide costs $250–400 per month from peptide suppliers as of mid-2026, with individual vials priced at $40–120 for 5 mg, $70–200 for 10 mg, and $150–400 for 20–30 mg depending on vendor and bulk-order status. That translates to roughly $0.80–$1.20 per milligram of active compound. These prices reflect the gray-market research-peptide economy—retatrutide is not FDA-approved, has no legitimate retail price, and is legally available only within Eli Lilly–sponsored clinical trials until anticipated approval in late 2027.

The compound's phase 3 data are extraordinary: the TRIUMPH-1 trial reported 28.3% mean weight loss at 80 weeks on the 12 mg dose, with nearly half of participants achieving ≥30% weight reduction—results that approach or rival bariatric surgery.[24][49] For context, semaglutide 2.4 mg (Wegovy) produces roughly 15% weight loss at 68 weeks, and tirzepatide 15 mg (Zepbound) around 21%, making retatrutide's 28–30% loss a meaningful step-change in pharmacologic obesity treatment.[19][24]

What Researchers Pay for Retatrutide

For a researcher running a 12 mg/week protocol mirroring the TRIUMPH-1 design, monthly costs land around $250–400 depending on order size and vendor tier. That's substantially below the projected commercial price once FDA approval hits: industry analysts expect a list price of $1,200–$1,500 per month for brand-name retatrutide pens, in line with Wegovy and Zepbound pricing.[29]

At $0.80–$1.20/mg in the research market versus an anticipated $2.50–$3.00/mg at retail launch, early adopters are accessing the compound at roughly one-third the expected commercial rate. That arbitrage window will close rapidly post-approval—the FDA has already clarified that retatrutide cannot be legally compounded under federal law, and has issued warnings about unapproved GLP-1 products sold online.[5][30]

Researchers sourcing retatrutide should prioritize vendors that provide third-party certificate-of-analysis (COA) testing showing ≥98% purity and endotoxin levels <10 EU/mg. NextGen Peptides and Swiss Chems maintain batch-level COA transparency. For those exploring FDA-approved alternatives, PeterMD offers tirzepatide and semaglutide with full clinical oversight. Vial presentation typically includes lyophilized powder requiring reconstitution with bacteriostatic water.

Clinical-Trial Dosing and Economics

The TRIUMPH phase 3 trials used a standardized escalation: 2 mg weekly for four weeks, then 4 mg, 6 mg, 9 mg, and finally 12 mg, reaching maintenance dose by approximately week 17.[40][49] That titration schedule minimizes gastrointestinal adverse events—nausea, vomiting, and diarrhea—which occur in 16–60% of participants at higher doses but are typically mild-to-moderate.[19][31][38]

The escalation phase is cheaper than maintenance: the first 16 weeks consume roughly 88 mg total. At $1/mg that's $88 for the titration period, or about $22/month. Once at 12 mg weekly maintenance, monthly costs jump to ~$400. Over a full year at 12 mg (after titration), total peptide spend runs roughly $4,000–$4,800 at current research-market rates versus an anticipated $14,000–$18,000 at projected retail pricing.

"I'm a researcher running a 9 mg protocol. Cost is about $280/month buying 30 mg vials. Weight is down 18% at six months, waist down 8 inches, fasting glucose normalized."
—User report on r/Retatrutide

The dose-response is steep: meta-analyses show 14.3% mean weight loss across all doses over 24–36 weeks, but the 12 mg dose in longer trials produces 28–30% loss while 4 mg produces roughly 10–12%.[3][19][24] For those interested in exploring advanced weight-management therapies alongside retatrutide, understanding the cost structure across the dose curve is essential. Additional context on peptide therapy protocols and metabolic optimization strategies can help researchers design effective regimens.

Frequently asked questions

How much does retatrutide cost per month online?

Research-grade retatrutide costs $250–400 per month from peptide suppliers as of mid-2026, depending on dosage and vendor. For a 12 mg/week protocol mirroring the TRIUMPH-1 clinical trial design, monthly costs land in this range when ordering from verified research-peptide suppliers. Individual vials are priced at $40–120 for 5 mg, $70–200 for 10 mg, and $150–400 for 20–30 mg depending on bulk-order status.

What is the cost difference between research retatrutide and the expected FDA-approved version?

Research-market retatrutide costs approximately one-third the expected commercial rate, with current pricing at $0.80–$1.20 per milligram versus an anticipated $2.50–$3.00 per milligram at retail launch. Industry analysts expect a list price of $1,200–$1,500 per month for brand-name retatrutide pens once FDA approval hits in late 2027, compared to the current $250–400 monthly cost in the research market. Over a full year at 12 mg weekly maintenance, total spend runs roughly $4,000–$4,800 at current rates versus an anticipated $14,000–$18,000 at projected retail pricing.

How much weight loss does retatrutide produce compared to other GLP-1 medications?

Retatrutide produces 28.3% mean weight loss at 80 weeks on the 12 mg dose according to the TRIUMPH-1 trial, with nearly half of participants achieving ≥30% weight reduction. For context, semaglutide 2.4 mg (Wegovy) produces roughly 15% weight loss at 68 weeks, and tirzepatide 15 mg (Zepbound) around 21%, making retatrutide's results approach or rival bariatric surgery outcomes. The 12 mg dose produces 28–30% loss while lower 4 mg doses produce roughly 10–12% weight loss.